title: The current place and indications of 131I-metaiodobenzylguanidine therapy in the era of peptide receptor radionuclide therapy: determinants to consider for evolving the best practice and envisioning a personalized approach.
authors.affiliation: Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Mumbai, Maharashtra, India.
authors.forename: Sandip
authors.initials: S
authors.lastname: Basu
authors.forename: Amit
authors.initials: A
authors.lastname: Abhyankar
authors.forename: Prafful
authors.initials: P
authors.lastname: Jatale
mesh_terms: D019797:3-Iodobenzylguanidine / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy; D057285:Precision Medicine / Q000379:methods*; D011878:Radiotherapy / Q000379:methods*; D018000:Receptors, Peptide / Q000378:metabolism*
chemical_list: D018000:Receptors, Peptide; D019797:3-Iodobenzylguanidine